Immunocore is expanding its ImmTAX platform into autoimmune disease, outlining plans to start first‑in‑human trials of ...

Strive Compounding Pharmacy alleges the two pharma companies are coordinating an effort to restrict compounded access.

The arrival of oral Wegovy across 70,000 US pharmacies offers a more affordable and convenient weight-loss treatment option ...

Despite lacklustre dealmaking, there were still trends identified from company presentations, such as pharma's upcoming ...

AstraZeneca has agreed to buy AbelZeta’s 50% stake in the China development and commercialisation rights for C-CAR031.

Novartis has announced that the FDA has granted a breakthrough therapy designation to ianalumab, a treatment for Sjögren’s ...

Public markets are showing early signs of reopening, as Q4 2025 saw a 157% increase in IPO deal volume compared to Q4 2024.

AbbVie’s lost exclusivity for Humira is offset by immunology and neurology sales, diversified by its emerging oncology ...

The funding aims to encourage innovation in Europe amid concerns that innovation across the continent is lagging behind China ...

Novo Nordisk is positioning itself as a long‑term leader across multiple obesity segments rather than relying on a single ...

The company will prioritise investment for in-house innovation over large M&A deals, bucking the trend across pharma.

Agenus has completed a $141m strategic collaboration with Zydus Lifesciences to accelerate the global development and ...